Familial Hypercholesterolemia (Type II Hyperlipoproteinemia):治療薬のグローバル治験動向(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) to Metabolic Disorders Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) to Metabolic Disorders Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Unaccomplished Trials of Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) 26
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Therapeutics Clinical Trials 31
Prominent Drugs 33
Latest Clinical Trials News on Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) 34
Mar 30, 2014: Data From Phase 3 Pivotal Studies Show Amgen’s Novel Investigational Cholesterol-Lowering Medication Evolocumab Significantly Reduced LDL Cholesterol In Statin Intolerant Patients And In Patients On Statins 34
Mar 27, 2014: Bococizumab (RN316) Significantly Reduced LDL Cholesterol In Statin-Treated Adults With High Cholesterol In A Phase 2b Study 36
Mar 17, 2014: Amgen Announces Positive Top-Line Results From Phase 3 TESLA Trial Of Evolocumab (AMG 145) In Patients With Homozygous Familial Hypercholesterolemia 37
Jan 28, 2014: Amgen Announces Positive Top-Line Results From Phase 3 LAPLACE-2 Trial Of Evolocumab (AMG 145) In Combination With Statins In Patients With High Cholesterol 38
Jan 23, 2014: Amgen Announces Positive Top-Line Results From Phase 3 GAUSS-2 Trial Of Evolocumab (AMG 145) In Statin Intolerant Patients With High Cholesterol 39
Clinical Trial Profiles 41
Clinical Trial Overview of Top Companies 41
Sanofi 41
Clinical Trial Overview of Sanofi 41
Aegerion Pharmaceuticals, Inc. 43
Clinical Trial Overview of Aegerion Pharmaceuticals, Inc. 43
Merck & Co., Inc. 45
Clinical Trial Overview of Merck & Co., Inc. 45
Pfizer Inc. 47
Clinical Trial Overview of Pfizer Inc. 47
Regeneron Pharmaceuticals, Inc. 48
Clinical Trial Overview of Regeneron Pharmaceuticals, Inc. 48
AstraZeneca PLC 49
Clinical Trial Overview of AstraZeneca PLC 49
Novartis AG 50
Clinical Trial Overview of Novartis AG 50
Amgen Inc. 51
Clinical Trial Overview of Amgen Inc. 51
Kowa Company, Ltd. 52
Clinical Trial Overview of Kowa Company, Ltd. 52
Daiichi Sankyo Company, Limited 53
Clinical Trial Overview of Daiichi Sankyo Company, Limited 53
Clinical Trial Overview of Top Institutes / Government 54
National Heart, Lung, and Blood Institute 54
Clinical Trial Overview of National Heart, Lung, and Blood Institute 54
University of Pennsylvania 55
Clinical Trial Overview of University of Pennsylvania 55
Central South University 56
Clinical Trial Overview of Central South University 56
Medical University of Vienna 57
Clinical Trial Overview of Medical University of Vienna 57
Emory University 58
Clinical Trial Overview of Emory University 58
Chinese University of Hong Kong 59
Clinical Trial Overview of Chinese University of Hong Kong 59
University of Sao Paulo 60
Clinical Trial Overview of University of Sao Paulo 60
VU University Medical Center 61
Clinical Trial Overview of VU University Medical Center 61
The Hospital for Sick Children 62
Clinical Trial Overview of The Hospital for Sick Children 62
National Center for Research Resources 63
Clinical Trial Overview of National Center for Research Resources 63
Five Key Clinical Profiles 64
Appendix 164
Abbreviations 164
Definitions 164
Research Methodology 165
Secondary Research 165
About GlobalData 166
Contact Us 166
Disclaimer 166
Source 166


【レポート販売概要】

■ タイトル:Familial Hypercholesterolemia (Type II Hyperlipoproteinemia):治療薬のグローバル治験動向(2014年上半期)
■ 英文:Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2014
■ 発行日:2014年5月15日
■ 調査会社:GlobalData
■ 商品コード:GDHC2138CTIDB
■ 調査対象地域:グローバル
  • 世界の高度道路交通システム(ITS)市場動向(2012-2016)
    TechNavio's analysts forecast the Global Intelligent Transportation System market to grow at a CAGR of 11.40 percent over the period 2012-2016. One of the key factors contributing to this market growth is the rapid growth of the Global Smart Cities market. The Global Intelligent Transportation System market has also been witnessing an increasing number of government initiatives promoting intellige …
  • 世界のプロセス安全システム市場動向(2012-2016)
    TechNavio's analysts forecast the Global Process Safety System market to grow at a CAGR of 11.28 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for safety systems from the Oil and Gas industry. The Global Process Safety System market has also been witnessing the increasing demand of safety system from the APAC region. However, …
  • 腎臓がん治療の世界市場動向及び予測
    Kidney Cancer Therapies – Now Explore Potentials of New Drugs, Industry Changes and Emerging Opportunities Are you interested in the future of renal cancer treatments? Our new study forecasts those pharmaceutical revenues. There you find outlooks for sales growth in that industry. You also explore trends, results, treatments, R&D and opportunities, seeing commercial prospects. Visiongain’s report …
  • 世界のモノクロル酢酸(MCA)市場2015
    The Global Monochloroacetic Acid (MCA) Industry Report 2015 is a professional and in-depth study on the current state of the Monochloroacetic Acid (MCA) industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Monochloroacetic Acid (MCA) market analysis is provided for the international markets including de …
  • 世界のポータブル空調装置市場:Global Portable Air Conditioning System Market 2014-2018
    TechNavio's analysts forecast the Global Portable Air Conditioning System market to grow at a CAGR of 12.56 percent over the period 2013-2018. One of the key factors contributing to this market growth is the high demand from North America and Europe. The Global Portable Air Conditioning System market has also been witnessing the increasing adoption of inverter-based portable air conditioners. Howe …
  • FRP/GRP/GREパイプの世界市場:ポリエステル、ポリウレタン、エポキシ、ガラス繊維、炭素繊維
    The global FRP pipe market size in terms of value is projected to grow at a CAGR of 3.5% between 2015 and 2020 to reach $4 billion by 2020. Asia-Pacific held the largest share in FRP pipe market in 2014. Major growth in Asia-Pacific FRP pipe market is due to the growth opportunities, considering significant demands from end application industries as chemical, oil and gas, retail fuel, water/waste …
  • 戦場管理システム(BMS)の世界市場2016-2020
    About Battlefield Management Systems A battlefield management system (BMS) provides the military unit with an integrated common operating picture (COP) that utilizes collaborative planning tools to enhance decision-making skills of the troops. This system provides the flexibility to manage and control events at combat level and also increases the probability for the mission success. The main purpo …
  • カタールの通信、モバイル、ブロードバンド市場
    Executive summary Qatar’s telecoms industry offers a number of opportunitiesGiven Qatar’s healthy telecommunications industry and corresponding infrastructure; developing the digital economy and broadband services are seen as a key potential growth area for the future. E-commerce in particular is expected to be a key growth area. While very few merchant’s currently offer online payment services in …
  • 前立腺がん治療の世界市場2016-2026
    What can be expected from the prostate cancer market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects there. Our 228-page report provides 213 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess …
  • 紫外線(UV)硬化型樹脂の世界市場分析:配合別(モノマー、オリゴマー、光開始剤)、用途別(木材コーティング、グラフィックアート、産業、自動車)、セグメント予測、2013-2024
    The global ultraviolet (UV) curable resins market is expected to reach USD 4.67 billion, according to a new report by Grand View Research, Inc. Rise in the industrial sector especially in Asia Pacific is one of the major driving factors for the growth of UV curable resins market. Increasing concern regarding growing VOC emissions has resulted in the development of new low emission products. UV cur …
  • 天然ガス自動車動向:Natural Gas Vehicles
    Dedicated natural gas vehicles (NGVs) are designed to run only on natural gas; bi-fuel NGVs have two separate fueling systems that enable the vehicle to use either natural gas or a conventional fuel (gasoline or diesel). There are over 150,000 natural gas vehicles on U.S. roads today and over five million worldwide. In general, dedicated NGVs demonstrate better performance and have lower emissions …
  • 肺がん治療ワクチンの世界市場及びパイプラインインサイト
    Lung cancer incidences are rapidly increasing and various therapeutics have been introduced in global market to provide better care to patients. Surgery and radiation therapy are not preferred for lung cancer treatment due to which they have small global market size. Chemotherapeutics and targeted therapeutics for lung cancer treatment are major market contender in global market with wide acceptan …
  • DBaaS(クラウド型データベースサービス)の世界市場2016-2020
    About the Database As A Service (DBaaS) Market Organizations across industries embrace cost-effective DBaaS solutions to meet their complex database management requirement and outperform their competitors. The need to gain flexibility while driving down data costs, the exponential growth in data due to increased implementation of enterprise mobility, and the rapid adoption of cloud computing posit …
  • リンパ浮腫診断の世界市場予測:リンシンシングラフィ、MRI、近赤外蛍光イメージング、超音波
    “The lymphedema diagnostics market is projected to grow at a CAGR of 7.4% during the forecast period.”The global lymphedema diagnostics market is projected to reach USD 35 million by 2024 from USD 24 million in 2019, at a CAGR of 7.4%. The major factors driving the growth of this market include the increasing global prevalence of cancer and lymphedema; technological advancements in diagnostic imag …
  • 電気自動車充電機器(EVSE)の世界市場予測2016-2026
    The latest report from business intelligence provider visiongain offers comprehensive analysis of the global EV supply equipment (EVSE) market. Visiongain assesses that the number of deployed EVSE will be over 2.2 million in 2016. EVSE is undeniably one of the fastest growing segments in the automotive sector. The report answer the following questions: • How is the EVSE market evolving and what is …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。